Navigation Links
Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
Date:12/2/2010

equirements under the medical benefit for Neulasta and Nplate. Under this program, eligible patients will incur no out of pocket costs for their first Nplate or Neulasta treatment associated with a new treatment regimen and will pay a maximum of $25 for subsequent injections. More information, eligibility requirements, restrictions and limitations about the co-pay coupon program are available at AmgenFIRSTSTEP.com.

SELECTED ABSTRACTS OF INTEREST INCLUDE:Abstracts are available on the ASH website at http://www.hematology.org and updated data will be presented at the meeting.

Nplate ITP Data

  • Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

  • (Abstract No. 68; Oral Presentation; Sunday, Dec. 5, 4:45 p.m. EST, room 230)

  • The Effects of Romiplostim or Standard of Care (SOC) on Splenectomy and Treatment Failure of Patients Who Had Immune Thrombocytopenia (ITP) for Less Than or Equal to One Year

  • (Abstract No. 3702; Poster III-481; Monday, Dec. 6, 6:00 p.m.-8:00 p.m. EST, Hall A3/A4)

  • Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP)

  • Abstract No. 3701; Poster III-480; Monday, Dec. 6, 6:00 p.m.-8:00 p.m. EST, Hall A3/A4)

  • Patient Quality of Life (QoL) in Nonsplenectomized Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim or Medical Standard of Care (SOC)

  • (Abstract No. 569; Oral Presentation; Monday, Dec. 6, 3:45 p.m. EST, Room 340)

  • Evaluation of Romiplostim in a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP)

  • (Abstract No. 3704; Poster III-483; Monday, Dec. 6, 6:00 p.m.-8:00 p.m. EST, Hall A3/A4)

  • Impact Assessment of
    '/>"/>

  • SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Amgen Foundation and Ashokas Changemakers Announce Finalists in Patients
    2. Choices
    3. Empowerment Competition
    4. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
    5. Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LAs Promise
    6. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
    7. Amgen Announces Webcast of 2010 Third Quarter Financial Results
    8. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
    9. Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
    10. Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
    11. Amgen and Pfizer Introduce Psophisticated Style: A Guide to Everyday Style and Psoriasis™ Hosted by Tim Gunn
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/14/2014)... PLYMOUTH, Minn. , Jan. 14, 2014   NuAire , a ... come to agreement with Hitachi Koki of ... centrifuges in North America . NuAire will utilize ... and Canada to offer assistance ...
    (Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
    (Date:1/14/2014)... , Jan. 14, 2014   Evidera , a leading ... that the Center for Drug Evaluation and Research (CDER), ... draft qualification guidance document for a patient-reported outcome (PRO) ... Chronic Pulmonary Disease Tool [EXACT] for Measurement of Symptoms ...
    Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
    ... in AMD patients, LOUISVILLE, Ky., Sept. 29 ... medicines for the treatment,of age-related macular degeneration (AMD) ... has shown early positive safety,results in its Phase ... shuts,down the complement activation cascade that could otherwise ...
    ... Sept. 26 Indevus Pharmaceuticals,Inc. (Nasdaq: ... signed a development,license and commercialization agreement with ... rights to pagoclone. Indevus previously,announced promising data ... II trial in patients with persistent stuttering ...
    Cached Medicine Technology:Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 3Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 4
    (Date:4/23/2014)... 2014 The American Society for Radiation Oncology (ASTRO) ... Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO ... radiation therapy in the treatment of endometrial cancer. ... May-June 2014 issue of Practical Radiation Oncology ... ASTRO. The full-length guideline is available as an ...
    (Date:4/23/2014)... pathway that helps prevent new cells from receiving too ... been directly linked to cancer and other diseases. , ... the end of cell division, the enzyme Cdc14 activates ... are fully repaired before the parent cell distributes copies ... safeguard against some of the most devastating genome errors, ...
    (Date:4/23/2014)... April 23, 2014Men whose testosterone falls below normal levels ... be overweight and have heart disease and type 2 ... testosterone-deficient men for further testing and possible treatment is ... Health , a peer-reviewed publication from Mary Ann Liebert, ... Journal of Men,s Health website at ...
    (Date:4/23/2014)... The American Gastroenterological Association (AGA) Research Foundation ... Scholars. The AGA Research Scholar Awards program, launched ... and productive research careers in digestive diseases. This ... additional year allowing for three consecutive years of ... faculty who are paving the way for promising ...
    (Date:4/23/2014)... In a country as wealthy as the United States, it ... do not have access to adequate food due to lack ... , Recent research at the University of Illinois using ... revealed that the seniors who are dealing with hunger are ... 2011, 8.35 percent of Americans over age 60 faced the ...
    Breaking Medicine News(10 mins):Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:More Americans in their golden years are going hungry 2
    ... C. Novelli as MDMA,s Director of Federal Affairs, ... Association (MDMA) is pleased to announce the appointment ... Federal Affairs., (Photo: http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO ), ... US Senate Committee on Finance,for Senator Charles Grassley ...
    ... agencies and scientists are tirelessly working to make manned ... Mars a reality. The technologies involved are awe-inspiring, but ... to face in an era of interplanetary exploration and, ... the European Science Foundation (ESF), European Space Agency (ESA) ...
    ... September 13 Elsevier today announced the,appointment ... and Government,Sales and Customer Marketing. In this ... marketing organization working directly with universities and,institutions ... research information,solutions, including ScienceDirect, Scopus, bibliographic databases ...
    ... 13 NuVasive, Inc. (Nasdaq:,NUVA), a medical device ... treatments for the spine, announced today,that Keith Valentine, ... Vice President and Chief Financial Officer, are,scheduled to ... at the St. Regis Hotel, in San Francisco, ...
    ... Latest SafeTrace Tx(R) User, DENVER, Sept. 13 ... today announced that its Wyndgate,Technologies(R) division has licensed ... of Puerto Rico and the Caribbean (CCPRC) to ... not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) ...
    ... Customize Wellness and Care Management Solutions for their ... Workforces, Consultative tailoring initially offered to customer ... ... market,success with employer wellness products such as Healthy Blue Living(SM) and,Healthy Blue Incentives(SM), Blue Cross ...
    Cached Medicine News:Health News:MDMA Names New Director of Federal Affairs 2Health News:Space scientists, humanist scholars to explore outer space from new perspective 2Health News:Space scientists, humanist scholars to explore outer space from new perspective 3Health News:Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing 2Health News:NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference 2Health News:NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference 3Health News:Global Med Technologies(R) Extends Its Worldwide Outreach 2Health News:Global Med Technologies(R) Extends Its Worldwide Outreach 3Health News:Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness 2Health News:Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness 3
    ... Nellcor NPB-290 and NPB-295 Pulse Oximeters ... provide accuracy, reliability and proven signal ... poorly perfused patients. Equipped with Oxismart ... Technology, these pulse oximeters identify electronic ...
    The Model 5340 is intended for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
    The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
    ... The Model 130 has expanded memory capabilities ... has memory to retain oxygen saturation and pulse ... modes to best suit your needs:, ,1. ... minutes of information for a single patient, making ...
    Medicine Products: